Paper6154658
In vivo natural reactivity of mice against tumor cells.
Riccardi C and 4 others. Int J Cancer, 1980. Cited by 175 papers, by iCite.
Cite this record
ConductScience Library. In vivo natural reactivity of mice against tumor cells. Papers, record 6154658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6154658
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Lymphoma | Major topic |
| Age Factors | |
| Animals | |
| Antibody-Dependent Cell Cytotoxicity | |
| Antineoplastic Agents | |
| Cell Line | |
| Cytotoxicity Tests, Immunologic | |
| Female | |
| Interferon Inducers | |
| Interferons | |
| Male | |
| Mice | |
| Mice, Inbred Strains | |
| Neoplasms, Experimental | |
| Species Specificity |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41769079 | Harnessing Natural Killer Cell-Mediated Innate Immune Responses for Cancer Treatment: Advances and Challenges. | Explor Res Hypothesis Med | 2022 | https://conductscience.org/library/papers/41769079 | PubMed |
| 38506114 | Stress in the metastatic journey - the role of cell communication and clustering in breast cancer progression and treatment resistance. | Dis Model Mech | 2024 | https://conductscience.org/library/papers/38506114 | PubMed |
| 35325068 | Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer. | Clin Exp Immunol | 2022 | https://conductscience.org/library/papers/35325068 | PubMed |
| 35289318 | The changing role of natural killer cells in cancer metastasis. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35289318 | PubMed |
| 35110548 | Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells. | Nat Commun | 2022 | https://conductscience.org/library/papers/35110548 | PubMed |
| 34868026 | Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response. | Front Immunol | 2021 | https://conductscience.org/library/papers/34868026 | PubMed |
| 29728948 | Potential impact of invasive surgical procedures on primary tumor growth and metastasis. | Clin Exp Metastasis | 2018 | https://conductscience.org/library/papers/29728948 | PubMed |
| 27072748 | Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. | Cancer Discov | 2016 | https://conductscience.org/library/papers/27072748 | PubMed |
| 26588681 | Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer. | Cancer J | 2015 | https://conductscience.org/library/papers/26588681 | PubMed |
| 26090481 | Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes. | J Immunol Res | 2015 | https://conductscience.org/library/papers/26090481 | PubMed |
| 23604045 | NK cell-based immunotherapy for malignant diseases. | Cell Mol Immunol | 2013 | https://conductscience.org/library/papers/23604045 | PubMed |
| 22532775 | Natural killer cells: role in local tumor growth and metastasis. | Biologics | 2012 | https://conductscience.org/library/papers/22532775 | PubMed |
| 21913338 | Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers. | Wiley Interdiscip Rev Syst Biol Med | 2012 | https://conductscience.org/library/papers/21913338 | PubMed |
| 19234170 | NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment. | J Immunol | 2009 | https://conductscience.org/library/papers/19234170 | PubMed |
| 12486249 | Intrinsic susceptibility of mouse trophoblasts to natural killer cell-mediated attack in vivo. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12486249 | PubMed |
| 9792148 | Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9792148 | PubMed |
| 8635195 | Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL). | Cancer Immunol Immunother | 1995 | https://conductscience.org/library/papers/8635195 | PubMed |
| 8306370 | 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8306370 | PubMed |
| 6984352 | Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF). | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6984352 | PubMed |
| 6572066 | Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6572066 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6154658
GET https://conductscience.org/api/papers/v1/6154658/cited_by?page=2